-
1
-
-
0033391691
-
Blood-brain barrier biology and methodology
-
Pardridge WM. Blood-brain barrier biology and methodology. J Neurovirol. 1999;5:556-569.
-
(1999)
J Neurovirol
, vol.5
, pp. 556-569
-
-
Pardridge, W.M.1
-
2
-
-
0036084919
-
Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation
-
Mark KS, Davis TP. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol. 2002;282:H1485-H1494.
-
(2002)
Am J Physiol Heart Circ Physiol
, vol.282
-
-
Mark, K.S.1
Davis, T.P.2
-
3
-
-
7044260589
-
Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier
-
Hayashi K, Nakao S, Nakaoke R, Nakagawa S, Kitagawa N, Niwa M. Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier. Regul Pept. 2004;123:77-83.
-
(2004)
Regul Pept
, vol.123
, pp. 77-83
-
-
Hayashi, K.1
Nakao, S.2
Nakaoke, R.3
Nakagawa, S.4
Kitagawa, N.5
Niwa, M.6
-
4
-
-
0036284832
-
Calcium modulation of adherens and tight junction function: A potential mechanism for blood-brain barrier disruption after stroke
-
Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke. 2002;33:1706-1711.
-
(2002)
Stroke
, vol.33
, pp. 1706-1711
-
-
Brown, R.C.1
Davis, T.P.2
-
5
-
-
4544382301
-
Bumetanide inhibition of the blood-brain barrier Na-K-Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke
-
O'Donnell ME, Tran L, Lam TI, Liu XB, Anderson SE. Bumetanide inhibition of the blood-brain barrier Na-K-Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke. J Cereb Blood Flow Metab. 2004;24:1046-1056.
-
(2004)
J Cereb Blood Flow Metab
, vol.24
, pp. 1046-1056
-
-
O'Donnell, M.E.1
Tran, L.2
Lam, T.I.3
Liu, X.B.4
Anderson, S.E.5
-
7
-
-
0035968623
-
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
-
PROGRESS Collaborative Group
-
PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
-
(2001)
Lancet
, vol.358
, pp. 1033-1041
-
-
-
8
-
-
0026669192
-
Functional involvement of P-glycoprotein in blood-brain barrier
-
Tatsuta T, Naito M, Oh-hara T, Sugawara I, Tsuruo T, Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem. 1992;267:20383-20391.
-
(1992)
J Biol Chem
, vol.267
, pp. 20383-20391
-
-
Tatsuta, T.1
Naito, M.2
Oh-hara, T.3
Sugawara, I.4
Tsuruo, T.5
-
9
-
-
3342933212
-
Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells
-
Dohgu S, Yamauchi A, Takata F, Naito M, Tsuruo T, Higuchi S, et al. Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell Mol Neurobiol. 2004;24:491-497.
-
(2004)
Cell Mol Neurobiol
, vol.24
, pp. 491-497
-
-
Dohgu, S.1
Yamauchi, A.2
Takata, F.3
Naito, M.4
Tsuruo, T.5
Higuchi, S.6
-
10
-
-
0026719204
-
Drug transfer across the blood-brain barrier: Correlation between in vitro and in vivo models
-
Dehouck MP, Jolliet-Riant P, Bree F, Fruchart JC, Cecchelli R, Tillement JP. Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. J Neurochem. 1992;58:1790-1797.
-
(1992)
J Neurochem
, vol.58
, pp. 1790-1797
-
-
Dehouck, M.P.1
Jolliet-Riant, P.2
Bree, F.3
Fruchart, J.C.4
Cecchelli, R.5
Tillement, J.P.6
-
11
-
-
0035930469
-
Adrenomedullin regulates blood-brain barrier functions in vitro
-
Kis B, Deli MA, Kobayashi H, Abraham CS, Yanagita T, Kaiya H, et al. Adrenomedullin regulates blood-brain barrier functions in vitro. Neuroreport. 2001;12:4139-4142.
-
(2001)
Neuroreport
, vol.12
, pp. 4139-4142
-
-
Kis, B.1
Deli, M.A.2
Kobayashi, H.3
Abraham, C.S.4
Yanagita, T.5
Kaiya, H.6
-
12
-
-
0035178147
-
Tissue plasminogen activator inhibits P-glycoprotein activity in brain endothelial cells
-
Deli MA, Abraham CS, Takahata H, Niwa M. Tissue plasminogen activator inhibits P-glycoprotein activity in brain endothelial cells. Eur J Pharmacol. 2001;411:R3-R5.
-
(2001)
Eur J Pharmacol
, vol.411
-
-
Deli, M.A.1
Abraham, C.S.2
Takahata, H.3
Niwa, M.4
-
13
-
-
0026589519
-
Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels
-
Ogawa S, Koga S, Kuwabara K, Brett J, Morrow B, Morris SA, et al. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am J Physiol. 1992;262:C546-C554.
-
(1992)
Am J Physiol
, vol.262
-
-
Ogawa, S.1
Koga, S.2
Kuwabara, K.3
Brett, J.4
Morrow, B.5
Morris, S.A.6
-
14
-
-
0030024463
-
Effects of barbiturates on hypoxic cultures of brain derived microvascular endothelial cells
-
Fischer S, Renz D, Schaper W, Karliczek GF. Effects of barbiturates on hypoxic cultures of brain derived microvascular endothelial cells. Brain Res. 1996;707:47-53.
-
(1996)
Brain Res
, vol.707
, pp. 47-53
-
-
Fischer, S.1
Renz, D.2
Schaper, W.3
Karliczek, G.F.4
-
15
-
-
0028177519
-
Indapamide alters the cyclic AMP signal transduction pathway in cardiomyocytes in culture
-
Rabkin SW. Indapamide alters the cyclic AMP signal transduction pathway in cardiomyocytes in culture. Eur J Pharmacol. 1994;266:117-123.
-
(1994)
Eur J Pharmacol
, vol.266
, pp. 117-123
-
-
Rabkin, S.W.1
|